Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Fig 2

Research Article

Targeting Ovarian Cancer Cell Cytotoxic Drug Resistance Phenotype with Xanthium strumarium L. Extract

Figure 2

XFC triggers late apoptosis in ES-2 ovarian cancer cells. Human ovarian clear cell carcinoma cells (ES-2) were cultured and treated with increasing concentrations of XFC in serum-free media for 24 or 48 hours, followed by fixation, PI staining, and (a) data acquisition by flow cytometry as described in Section 2 to assess cell death phases. (b) Data analysis was also performed as described in Section 2 in order to assess levels of live cells, early apoptosis, late apoptosis, and necrosis.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.